Nathifa A. Moyo, PhD
Senior Staff Scientist
Immunology and Vaccine Development, Vaccine and Infectious Disease Division, Fred Hutch
Senior Staff Scientist
HIV Vaccine Trials Network (HVTN) and Coronavirus Prevention Network (CoVPN) Leadership Center, Fred Hutch
Research focus includes direct care for individuals living with HIV infection, tropical and parasitic infections, and infections caused by nontuberculous mycobacteria. Provide scientific and clinical oversight and project management for the development and execution of HIV vaccine and monoclonal antibody trials.
Education
University of Oxford, The Jenner Institute for Vaccine Research, 2016 -2021, Senior Postdoctoral Immunologist in HIV Vaccine Development
University of Liverpool, 2013-2016, Postdoctoral Research Associate in Infection Biology
University of Surrey, 2013, PhD (Immunology & Virology)
University of Surrey, 2008, MS (Medical Microbiology)
University of the West Indies, 2003, BS (Biology and Biochemistry, Double Major)
Research Interests
Characterizing antigen specific immune responses to vaccines and infection
HIV-1 vaccine development
Understanding human immune mechanisms that control and prevent HIV infection
Human T cell biology
Current Projects
HIV Vaccine Trials Network (HVTN) Laboratory